These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6339126)

  • 1. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
    De Fernandez MA; Clark A; Triger DR
    Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil function in chronic liver disease.
    Campbell AC; Dronfield MW; Toghill PJ; Reeves WG
    Clin Exp Immunol; 1981 Jul; 45(1):81-9. PubMed ID: 7030541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.
    Potter BJ; Elias E; Thomas HC; Sherlock S
    Gastroenterology; 1980 May; 78(5 Pt 1):1034-40. PubMed ID: 7380176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in chronic liver disease.
    Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
    Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.
    Yeaman GR; Kerr MA
    Clin Exp Immunol; 1987 Apr; 68(1):200-8. PubMed ID: 3308208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the serum defect in yeast opsonization in children with fulminant hepatic failure (FHF).
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Clin Exp Immunol; 1981 Nov; 46(2):406-11. PubMed ID: 7039888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.
    Jaffe CJ; Vierling JM; Jones EA; Lawley TJ; Frank MM
    J Clin Invest; 1978 Nov; 62(5):1069-77. PubMed ID: 711852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.
    Saxena S; Nouri-Aria KT; Anderson MG; Eddleston AL; Williams R
    Clin Exp Immunol; 1986 Mar; 63(3):541-8. PubMed ID: 3486732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in phagocytic performance of neutrophilic granulocytes in chronic liver diseases of various etiologies].
    Königstedt B; Zipprich B; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(1):8-15. PubMed ID: 3720634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen-derived free radical production by peripheral blood neutrophils in chronic cholestatic liver diseases.
    D'Odorico A; Melis A; Baragiotta A; Martines D; Naccarato R; Floreani A
    Hepatogastroenterology; 1999; 46(27):1831-5. PubMed ID: 10430355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.
    Turner MW; Grant C; Seymour ND; Harvey B; Levinsky RJ
    Immunology; 1986 May; 58(1):111-5. PubMed ID: 3519441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects of serum chemoattraction and polymorphonuclear leucocyte movement in patients with primary hepatocellular carcinoma.
    Yousif-Kadaru AG; Wyke RJ; Rajkovic IA; Eddleston AL; Williams R
    Clin Exp Immunol; 1982 Aug; 49(2):467-73. PubMed ID: 6290116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoglobulinemia in chronic liver diseases.
    Shoenfeld Y; Berliner S; Neeman A; Kadish U; Pinkhas J
    Am J Gastroenterol; 1980 Nov; 74(5):439-40. PubMed ID: 7234822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of serum complement levels in chronic liver disease.
    Finlayson ND; Krohn K; Fauconnet MH; Anderson KE
    Gastroenterology; 1972 Oct; 63(4):653-9. PubMed ID: 4116547
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphonuclear leucocyte locomotion and aggregation in patients with alcoholic liver disease.
    Rajkovic IA; Yousif-Kadaru AG; Wyke RJ; Williams R
    Clin Exp Immunol; 1984 Dec; 58(3):654-62. PubMed ID: 6509797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
    Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
    Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of granulocytes and monocytes in primary biliary and alcoholic cirrhosis.
    Blussé van Oud A; Janssens AR; Leijh PC; van Furth R
    Clin Exp Immunol; 1985 Dec; 62(3):724-31. PubMed ID: 4085152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative in vitro studies of cell-mediated immunity in chronic liver diseases].
    Königstedt B; Zipprich R; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):113-21. PubMed ID: 3487441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.